Amperos Health Accelerates AI Revolution in Healthcare Revenue Recovery
April 27, 2026, 3:37 am
Location: United States, California, San Francisco
Employees: 51-200
Founded date: 1911
Amperos Health secured $16M Series A funding, launching its AI-native platform to revolutionize healthcare revenue recovery. This agentic AI system autonomously manages denied claims—navigating portals, calling insurers, and submitting appeals. The end-to-end solution slashes operational costs by up to 50% and boosts claim recovery rates by over 20%. It resolves denials five times faster. Addressing the $262 billion annual loss from denied claims, Amperos currently supports 3,000+ clinical locations, recovering nearly $700 million yearly. New capital accelerates growth, expanding AI capabilities into RCM workflows and enhancing analytics. Providers optimize financial health, focusing on care.
Healthcare providers face immense financial pressure. Denied insurance claims represent a significant burden. In 2024, approximately 12% of healthcare claims were rejected. This translated to a staggering $262 billion loss for providers. Traditional revenue cycle management (RCM) teams struggle. They contend with chronic understaffing. High turnover rates compound the problem. Manual processes are slow. They are also error-prone. These issues directly impact provider solvency. They divert resources from patient care.
Amperos Health now offers a powerful solution. The company recently closed a $16 million Series A funding round. Bessemer Venture Partners led this investment. Uncork Capital and Neo also participated. This capital infusion follows a successful $4.2 million seed round in June 2025. The funding fuels the expansion of Amperos’ innovative platform. This platform uses cutting-edge AI. It targets the heart of the denial management crisis.
Amperos developed an industry-first platform. It is AI-native. It offers end-to-end denial management. This system transcends existing fragmented tools. Many solutions only draft appeal letters. Others provide predictive scoring. Amperos employs agentic AI. This advanced technology leverages state-of-the-art large language models (LLMs). These LLMs possess computer and voice capabilities. They act autonomously. The AI independently navigates payer portals. It makes calls to insurers. It submits corrected claims. The entire process is automated.
Human expertise remains vital. A dedicated team of Amperos subject matter experts provides oversight. They offer judgment for highly complex claims. These difficult-to-recover cases require human nuance. The system creates a powerful human-in-the-loop synergy. This hybrid approach ensures both efficiency and accuracy. It maximizes recovery potential.
The financial returns are compelling. Amperos resolves denials five times faster than traditional methods. Customers report up to 50% lower costs. This compares favorably to traditional outsourced vendors. Furthermore, providers recover over 20% more revenue per claim. Some see 22% higher recovery rates. The platform reduces overall denial rates by up to 70%. It offers measurable financial relief.
Amperos demonstrates proven scale. The platform serves over 3,000 clinical locations. It spans all 50 states. It has recovered nearly $700 million annually. This covers more than 500,000 claims. One example is DOCS Dermatology. A Vice President of Revenue Cycle Management reported significant gains. The organization recovered 24% more claims. This occurred without increasing staff headcount. Such results underscore the platform’s impact.
The technology continuously learns. Amperos’ proprietary LLMs manage the full lifecycle of a denial. This includes automated insurance follow-up. It handles portal navigation. It conducts calls to insurers. End-to-end resolution encompasses submitting corrected claims and medical records. It also drafts complex appeals. The AI benchmarks its performance against human specialists. This refines strategies. It adapts as payer behaviors change. Insurers deploy their own algorithms to deny care. Health systems now possess the necessary firepower. They can fight back effectively and at scale.
The new funding will accelerate Amperos’ strategic growth. It will expand into other RCM workflows. It will enhance analytics capabilities. The platform fills critical gaps in the RCM workforce. This empowers existing staff. They can focus on high-complexity claims. These cases demand human judgment. The AI handles the high-volume, repetitive tasks. This optimizes staff utilization.
Amperos' mission is clear. Complexity in healthcare revenue cycle management should not be the norm. The company streamlines denial and collections processes. Providers can then focus on their core mission. They can deliver patient care. This technological advancement represents a paradigm shift. It offers a new era of financial stability for healthcare organizations. Amperos stands at the forefront of this transformation. It redefines healthcare revenue recovery. It builds a more efficient, financially robust healthcare ecosystem.
Healthcare providers face immense financial pressure. Denied insurance claims represent a significant burden. In 2024, approximately 12% of healthcare claims were rejected. This translated to a staggering $262 billion loss for providers. Traditional revenue cycle management (RCM) teams struggle. They contend with chronic understaffing. High turnover rates compound the problem. Manual processes are slow. They are also error-prone. These issues directly impact provider solvency. They divert resources from patient care.
Amperos Health now offers a powerful solution. The company recently closed a $16 million Series A funding round. Bessemer Venture Partners led this investment. Uncork Capital and Neo also participated. This capital infusion follows a successful $4.2 million seed round in June 2025. The funding fuels the expansion of Amperos’ innovative platform. This platform uses cutting-edge AI. It targets the heart of the denial management crisis.
Amperos developed an industry-first platform. It is AI-native. It offers end-to-end denial management. This system transcends existing fragmented tools. Many solutions only draft appeal letters. Others provide predictive scoring. Amperos employs agentic AI. This advanced technology leverages state-of-the-art large language models (LLMs). These LLMs possess computer and voice capabilities. They act autonomously. The AI independently navigates payer portals. It makes calls to insurers. It submits corrected claims. The entire process is automated.
Human expertise remains vital. A dedicated team of Amperos subject matter experts provides oversight. They offer judgment for highly complex claims. These difficult-to-recover cases require human nuance. The system creates a powerful human-in-the-loop synergy. This hybrid approach ensures both efficiency and accuracy. It maximizes recovery potential.
The financial returns are compelling. Amperos resolves denials five times faster than traditional methods. Customers report up to 50% lower costs. This compares favorably to traditional outsourced vendors. Furthermore, providers recover over 20% more revenue per claim. Some see 22% higher recovery rates. The platform reduces overall denial rates by up to 70%. It offers measurable financial relief.
Amperos demonstrates proven scale. The platform serves over 3,000 clinical locations. It spans all 50 states. It has recovered nearly $700 million annually. This covers more than 500,000 claims. One example is DOCS Dermatology. A Vice President of Revenue Cycle Management reported significant gains. The organization recovered 24% more claims. This occurred without increasing staff headcount. Such results underscore the platform’s impact.
The technology continuously learns. Amperos’ proprietary LLMs manage the full lifecycle of a denial. This includes automated insurance follow-up. It handles portal navigation. It conducts calls to insurers. End-to-end resolution encompasses submitting corrected claims and medical records. It also drafts complex appeals. The AI benchmarks its performance against human specialists. This refines strategies. It adapts as payer behaviors change. Insurers deploy their own algorithms to deny care. Health systems now possess the necessary firepower. They can fight back effectively and at scale.
The new funding will accelerate Amperos’ strategic growth. It will expand into other RCM workflows. It will enhance analytics capabilities. The platform fills critical gaps in the RCM workforce. This empowers existing staff. They can focus on high-complexity claims. These cases demand human judgment. The AI handles the high-volume, repetitive tasks. This optimizes staff utilization.
Amperos' mission is clear. Complexity in healthcare revenue cycle management should not be the norm. The company streamlines denial and collections processes. Providers can then focus on their core mission. They can deliver patient care. This technological advancement represents a paradigm shift. It offers a new era of financial stability for healthcare organizations. Amperos stands at the forefront of this transformation. It redefines healthcare revenue recovery. It builds a more efficient, financially robust healthcare ecosystem.